Bank of Montreal’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $240K | Buy |
70,089
+22,155
| +46% | +$76K | ﹤0.01% | 2417 |
|
|
2025
Q1 | $107K | Sell |
47,934
-3,513
| -7% | -$7.83K | ﹤0.01% | 2629 |
|
|
2024
Q4 | $151K | Sell |
51,447
-6,566
| -11% | -$19.2K | ﹤0.01% | 2548 |
|
|
2024
Q3 | $151K | Buy |
58,013
+16,354
| +39% | +$42.7K | ﹤0.01% | 2810 |
|
|
2024
Q2 | $124K | Sell |
41,659
-2,468
| -6% | -$7.36K | ﹤0.01% | 2891 |
|
|
2024
Q1 | $199K | Buy |
44,127
+12,684
| +40% | +$57.1K | ﹤0.01% | 2755 |
|
|
2023
Q4 | $187K | Sell |
31,443
-30,081
| -49% | -$179K | ﹤0.01% | 2754 |
|
|
2023
Q3 | $331K | Sell |
61,524
-2,918
| -5% | -$15.7K | ﹤0.01% | 2352 |
|
|
2023
Q2 | $489K | Sell |
64,442
-4,375
| -6% | -$33.2K | ﹤0.01% | 2267 |
|
|
2023
Q1 | $521K | Buy |
68,817
+5,380
| +8% | +$40.7K | ﹤0.01% | 2196 |
|
|
2022
Q4 | $644K | Sell |
63,437
-83,311
| -57% | -$845K | ﹤0.01% | 2091 |
|
|
2022
Q3 | $1.55K | Sell |
146,748
-190,902
| -57% | -$2.02K | ﹤0.01% | 1654 |
|
|
2022
Q2 | $3.47K | Buy |
337,650
+209,148
| +163% | +$2.15K | ﹤0.01% | 1348 |
|
|
2022
Q1 | $1.27M | Buy |
128,502
+25,528
| +25% | +$251K | ﹤0.01% | 1808 |
|
|
2021
Q4 | $1.5M | Sell |
102,974
-12,490
| -11% | -$181K | ﹤0.01% | 1694 |
|
|
2021
Q3 | $2.25M | Buy |
115,464
+42,974
| +59% | +$836K | ﹤0.01% | 1846 |
|
|
2021
Q2 | $1.55M | Buy |
72,490
+3,767
| +5% | +$80.3K | ﹤0.01% | 2095 |
|
|
2021
Q1 | $2.1M | Buy |
68,723
+62,279
| +966% | +$1.9M | ﹤0.01% | 1536 |
|
|
2020
Q4 | $236K | Buy |
+6,444
| New | +$236K | ﹤0.01% | 2696 |
|